NCT02139943: A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM) |
|
|
| Completed | 2 | 352 | US, Canada | Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo | Janssen Research & Development, LLC | Diabetes Mellitus, Type 1 | 06/15 | 06/15 | | |
